135 related articles for article (PubMed ID: 28981199)
1. MicroRNA-661 modulates redox and metabolic homeostasis in colon cancer.
Gómez de Cedrón M; Acín Pérez R; Sánchez-Martínez R; Molina S; Herranz J; Feliu J; Reglero G; Enríquez JA; Ramírez de Molina A
Mol Oncol; 2017 Dec; 11(12):1768-1787. PubMed ID: 28981199
[TBL] [Abstract][Full Text] [Related]
2. Oxystressed tumor microenvironment potentiates epithelial to mesenchymal transition and alters cellular bioenergetics towards cancer progression.
Sridaran D; Ramamoorthi G; MahaboobKhan R; Kumpati P
Tumour Biol; 2016 Oct; 37(10):13307-13322. PubMed ID: 27460079
[TBL] [Abstract][Full Text] [Related]
3. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes.
Lunetti P; Di Giacomo M; Vergara D; De Domenico S; Maffia M; Zara V; Capobianco L; Ferramosca A
FEBS J; 2019 Feb; 286(4):688-709. PubMed ID: 30657636
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine architecture-dependent metabolic imprints and perturbation of cellular redox homeostasis.
Hall A; Parhamifar L; Lange MK; Meyle KD; Sanderhoff M; Andersen H; Roursgaard M; Larsen AK; Jensen PB; Christensen C; Bartek J; Moghimi SM
Biochim Biophys Acta; 2015 Mar; 1847(3):328-342. PubMed ID: 25482261
[TBL] [Abstract][Full Text] [Related]
5. Role of mitochondrial function in the invasiveness of human colon cancer cells.
Lin CS; Liu LT; Ou LH; Pan SC; Lin CI; Wei YH
Oncol Rep; 2018 Jan; 39(1):316-330. PubMed ID: 29138850
[TBL] [Abstract][Full Text] [Related]
6. The mitochondrial carrier SLC25A10 regulates cancer cell growth.
Zhou X; Paredes JA; Krishnan S; Curbo S; Karlsson A
Oncotarget; 2015 Apr; 6(11):9271-83. PubMed ID: 25797253
[TBL] [Abstract][Full Text] [Related]
7. Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer.
Tai Y; Cao F; Li M; Li P; Xu T; Wang X; Yu Y; Gu B; Yu X; Cai X; Ao F; Ge P; Xiang L; Yang B; Jiang Y; Li Y
Redox Biol; 2019 Jan; 20():451-457. PubMed ID: 30439686
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
9. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA.
Serguienko A; Grad I; Wennerstrøm AB; Meza-Zepeda LA; Thiede B; Stratford EW; Myklebost O; Munthe E
Oncotarget; 2015 Feb; 6(4):2451-65. PubMed ID: 25669981
[TBL] [Abstract][Full Text] [Related]
10. Rewiring carbohydrate catabolism differentially affects survival of pancreatic cancer cell lines with diverse metabolic profiles.
Tataranni T; Agriesti F; Ruggieri V; Mazzoccoli C; Simeon V; Laurenzana I; Scrima R; Pazienza V; Capitanio N; Piccoli C
Oncotarget; 2017 Jun; 8(25):41265-41281. PubMed ID: 28476035
[TBL] [Abstract][Full Text] [Related]
11. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome b5 reductase, a plasma membrane redox enzyme, protects neuronal cells against metabolic and oxidative stress through maintaining redox state and bioenergetics.
Hyun DH; Lee GH
Age (Dordr); 2015 Dec; 37(6):122. PubMed ID: 26611738
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.
Wang Y; Li Y; Wu B; Shi C; Li C
Mol Med Rep; 2017 Aug; 16(2):2113-2120. PubMed ID: 28656235
[TBL] [Abstract][Full Text] [Related]
14. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
15. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
[TBL] [Abstract][Full Text] [Related]
17. ROS homeostasis and metabolism: a dangerous liason in cancer cells.
Panieri E; Santoro MM
Cell Death Dis; 2016 Jun; 7(6):e2253. PubMed ID: 27277675
[TBL] [Abstract][Full Text] [Related]
18. Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden.
Prinz C; Vasyutina E; Lohmann G; Schrader A; Romanski S; Hirschhäuser C; Mayer P; Frias C; Herling CD; Hallek M; Schmalz HG; Prokop A; Mougiakakos D; Herling M
Mol Cancer; 2015 Jun; 14():114. PubMed ID: 26041471
[TBL] [Abstract][Full Text] [Related]
19. Combined arginine and ascorbic acid treatment induces apoptosis in the hepatoma cell line HA22T/VGH and changes in redox status involving the pentose phosphate pathway and reactive oxygen and nitrogen species.
Hsieh BS; Huang LW; Su SJ; Cheng HL; Hu YC; Hung TC; Chang KL
J Nutr Biochem; 2011 Mar; 22(3):234-41. PubMed ID: 20558052
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial metabolism-mediated redox regulation in cancer progression.
Boese AC; Kang S
Redox Biol; 2021 Jun; 42():101870. PubMed ID: 33509708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
